US78667J1088 - Common Stock
SAGE THERAPEUTICS INC
NASDAQ:SAGE (5/20/2024, 5:21:29 PM)
After market: 11.25 +0.07 (+0.63%)11.18
-0.52 (-4.44%)
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 689 full-time employees. The company went IPO on 2014-07-18. The firm is focused on developing and commercializing brain health medicines. The firm's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD) in adults. The company has a portfolio of other product candidates with a focus on modulating two central nervous systems (CNS) receptor systems, GABA and NMDA. The company targets diseases and disorders of the brain with three focus areas: depression, neurology and neuropsychiatry. Its other advanced product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder (MDD) and PPD. Zuranolone is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. The firm has a portfolio of other compounds that target GABAA receptors, including SAGE-324.
SAGE THERAPEUTICS INC
215 1st St
Cambridge MASSACHUSETTS 02142
P: 16172998380
CEO: Barry E. Greene
Employees: 689
Website: https://www.sagerx.com/
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE). Such...
Here you can normally see the latest stock twits on SAGE, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: